Picture of Cellectar Biosciences logo

CLRB Cellectar Biosciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Cellectar Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:10-Q10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments1013.310.657.235.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets10.51411.457.936.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.2450.5430.7840.6380.549
Net Goodwill
Other Long Term Assets
Total Assets12.915.112.358.737.2
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities2.111.622.773.563.99
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities2.121.793.193.864.16
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity10.813.39.0654.833
Total Liabilities & Shareholders' Equity12.915.112.358.737.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding

Or unlock with your email

Or unlock with your email